| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-05 |